Advertiser / Brand
HERMES ARZNEIMITTEL vs URSAPHARM
Structured technology and market comparison · 2026
Direct Feature Comparison
HERMES ARZNEIMITTEL · vs · URSAPHARMGerman OTC pharmaceuticals and consumer health brand company.
German ophthalmic pharmaceutical manufacturer with international distribution.
Analyze all overlapping signals and tech stacks for HERMES ARZNEIMITTEL and URSAPHARM
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between HERMES ARZNEIMITTEL and URSAPHARM?
When comparing HERMES ARZNEIMITTEL and URSAPHARM, both platforms operate within the Other / Non-Digital Advertising Relevant ecosystem. HERMES ARZNEIMITTEL is positioned as German OTC pharmaceuticals and consumer health brand company, whereas URSAPHARM focuses on German ophthalmic pharmaceutical manufacturer with international distribution. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to HERMES ARZNEIMITTEL and URSAPHARM?
When evaluating HERMES ARZNEIMITTEL and URSAPHARM, enterprise buyers also consider other platforms in Other / Non-Digital Advertising Relevant. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of HERMES ARZNEIMITTEL and URSAPHARM compare?
HERMES ARZNEIMITTEL is headquartered in DE (founded in 1907) with 50–200 employees. URSAPHARM is based in DE (founded in 1974) with 501–1,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: HERMES ARZNEIMITTEL vs URSAPHARM
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
HERMES ARZNEIMITTEL
Recent Signals
- ·HorizontAgency & Consultancy
Havas Retains Hermes Arzneimittel Media Account
Havas Media’s Frankfurt office has been confirmed as Hermes Arzneimittel’s media agency after winning a multi-stage pitch. From 2027 the agency will take responsibility for the full media budget — including digital activities — in an assignment valued in the mid single-digit million euro range. Havas, which has served Hermes since 2013, will assume additional brand duties that, together with digital responsibilities, will double the media volume it manages for the client. Hermes’ brands cited include Antibrumm (Anti Brumm), Compeed (blister plasters), Algorvir (algovir), Biolectra Magnesium, Betaisodona and doc. The win was reported by Horizont on 17 August 2026.
- Havas Media (Frankfurt) won Hermes Arzneimittel’s full media account following a multi-stage pitch.
- Havas will assume responsibility for the account from 2027, including digital activities.
- The account is valued in the mid single-digit million euro range.
URSAPHARM
Recent Signals
- ·URSAPHARM
URSAPHARM und der FC Bayern bauen erfolgreiche Partnerschaft weiter aus
Die URSAPHARM Arzneimittel GmbH und der FC Bayern München setzen ihre erfolgreiche Zusammenarbeit fort. Mit HYLO®, dem marktführenden Sortiment im Bereich der Befeuchtung trockener Augen, bleibt URSAPHARM bis 2029 Gold Partner der ersten Herrenmannschaft des deutschen Rekordmeisters. Gleichzeitig wird die Partnerschaft strategisch ausgebaut: Neben einer stärkeren Ausrichtung auf die asiatischen Märkte […]
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners HERMES ARZNEIMITTEL and URSAPHARM share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks